COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2022 · PMC8579248 · PMID 34753828

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

a nonsignificant trendp = 0.051so close (0.05 < p ≤ 0.1)

Non-White participants were less likely to report experiencing a vaccine reaction compared with White participants (OR = 0.4; 95% CI: 0.19–0.86; p = 0.018), and there was a nonsignificant trend for fewer reactions among participants on S1PR modulators compared with those who were not actively on a DMT (OR = 0.50; 95% CI: 0.26–1.0; p = 0.051; Figure 1, C and E ; eTable 1, links.lww.com/NXI/A651 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.